Home
Continued Medical Education
Cancer A – Z
Leukemia
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Physician’s Weekly
Oncology Hematology (General)
Chemotherapy
Colon Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Myleoma
Ovarian Cancer
Prostate Cancer
Renal Cell Carcinoma
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Onco’Zine Brief Episodes
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
UK Health Radio
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
Programs | Shows
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
COVID19 – Cancelled Medical Meetings 2020
Oncology Directory
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Continued Medical Education
Cancer A – Z
Leukemia
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Physician’s Weekly
Oncology Hematology (General)
Chemotherapy
Colon Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Myleoma
Ovarian Cancer
Prostate Cancer
Renal Cell Carcinoma
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Onco’Zine Brief Episodes
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
UK Health Radio
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
Programs | Shows
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
COVID19 – Cancelled Medical Meetings 2020
Oncology Directory
Join Today
Event Agenda
Video
Careers
Home
Op-Ed | Opinion
Page 3
Op-Ed | Opinion
Op-Ed | Opinion
A Spaceship on Mars and Screening for Gynecologic Cancer
Valena Wrtight, MD
-
April 6, 2021
Are Cytology and Imaging Adequate for the Diagnostic Management of Brain Metastasis?
Revealing the Blind Spot in Cancer Treatment with Host Response Profiling
The History, Reality and Promise of Immunotherapy for Cancer
Improving Lung Cancer Patient Access to Comprehensive Biomarker Testing
Transparency and Openness – A Must in the Murky World of...
LaMar Williams, Jr.
-
August 30, 2019
Personalizing Cancer Treatment: Why Adaptive Therapy Isn’t There Yet
Yves Archambault
-
August 21, 2019
No Rural Patient Left Behind: The Quest to Democratize Access to...
Jani Ahonala
-
August 2, 2019
A Call to Action: Addressing Healthcare Diversity Among Hispanic/Latino People in...
Mario Anglada
-
August 1, 2019
Erdafitinib, the First-Ever Targeted Therapy for Bladder Cancer, Receives Accelerated FDA...
Adil J. Akhtar, MD
-
July 18, 2019
Combination Therapy, Combating Cancer from Multiple Flanks
Isaac Israel
-
July 9, 2019
Stopping Triple-negative Breast Cancer in its Tracks
Salman M. Hyder, PhD
-
May 24, 2019
How Anesthesiologists Are Fighting the Opioid Crisis
Lynnus Peng, MD
-
May 21, 2019
Marshalling Chemotherapy, Radiotherapy and the Immune System to Fight Cancer
Greg Van Wyk
-
May 17, 2019
As New Drugs Lag, Accelerated Clinical Trials Lead Charge in Brain...
Nader Sanai, MD, FAANS, FACS
-
April 12, 2019
1
2
3
4
Page 3 of 4
LATEST NEWS
AmunBio and NorthShore University to Advance Cancer Immunotherapy with Engineered Oncolytic Viruses
Peter Hofland, Ph.D
-
April 13, 2021
A Spaceship on Mars and Screening for Gynecologic Cancer
Valena Wrtight, MD
-
April 6, 2021
Are Cytology and Imaging Adequate for the Diagnostic Management of Brain Metastasis?
Michael C. Dugan, M.D.
-
April 1, 2021
Combination of SLC-391 + Pembrolizumab Enters Clinical Trial Advanced NSCLC
Peter Hofland, Ph.D
-
March 31, 2021
Revealing the Blind Spot in Cancer Treatment with Host Response Profiling
Ofer Sharon, MD, MBA
-
March 22, 2021